Orbimed Advisors LLC Portfolio Holdings

Orbimed Advisors LLC

  • $3.21 Billion
  • Q1 2025

Orbimed Advisors LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $3.21 Billion distributed in 111 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Edgewise Therapeutics, Inc. with a value of $330M, Boston Scientific Corp with a value of $284M, Eli Lilly & CO with a value of $279M, Intuitive Surgical Inc with a value of $144M, and Stryker Corp with a value of $134M.

Examining the 13F form we can see an decrease of $483M in the current position value, from $3.69B to 3.21B.

Orbimed Advisors LLC is based out at San Diego, CA

Below you can find more details about Orbimed Advisors LLC portfolio as well as his latest detailed transactions.

Portfolio value $3.21 Billion
Healthcare: $3.2 Billion
ETFs: $8.11 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$929M
$330 Million 10.3% of portfolio
15,021,721
Q1 2024 Added 3.12%
$145B
$284 Million 8.85% of portfolio
2,813,200
Q1 2025 Reduced 10.98%
$746B
$279 Million 8.69% of portfolio
337,600
Q2 2024 Reduced 6.43%
$180B
$144 Million 4.49% of portfolio
291,000
Q1 2025 Reduced 27.56%
$141B
$134 Million 4.17% of portfolio
359,200
Q1 2025 Added 4.3%
$29.8B
$122 Million 3.81% of portfolio
206,700
Q1 2025 Added 8.96%
$45.7B
$111 Million 3.46% of portfolio
1,532,000
Q1 2025 Added 33.76%
$287B
$105 Million 3.28% of portfolio
201,200
Q1 2025 Added 53.71%
$12.2B
$103 Million 3.22% of portfolio
934,640
Q1 2025 Reduced 0.37%
$134B
$97.6 Million 3.04% of portfolio
3,850,200
Q1 2025 New
$38.4B
$93.5 Million 2.91% of portfolio
346,100
Q1 2025 Reduced 16.72%
$3.92B
$78.2 Million 2.44% of portfolio
662,500
Q1 2025 Added 15.22%
$115B
$77.5 Million 2.42% of portfolio
159,900
Q1 2025 Added 5.89%
$16.3B
$77.4 Million 2.41% of portfolio
547,000
Q1 2025 Added 32.45%
$5.25B
$76.6 Million 2.39% of portfolio
2,540,136
Q1 2025 Reduced 9.84%
$154B
$64.2 Million 2.0% of portfolio
129,000
Q1 2025 Added 52.84%
$3.18B
$60.7 Million 1.89% of portfolio
1,509,205
Q1 2025 Reduced 4.72%
$1.55B
$53.5 Million 1.67% of portfolio
1,812,886
Q1 2025 Added 62.9%
$596M
$48.3 Million 1.51% of portfolio
3,442,853
Q4 2024 Added 4.15%
$4.36B
$45.1 Million 1.41% of portfolio
386,700
Q1 2025 New
$239M
$42.5 Million 1.32% of portfolio
22,362,850
Q4 2022 Added 1.83%
$2.92B
$41.9 Million 1.31% of portfolio
950,200
Q1 2025 Reduced 24.29%
$270M
$41.9 Million 1.3% of portfolio
3,406,335
Q2 2024 Reduced 14.93%
$64.9M
$34.4 Million 1.07% of portfolio
73,114,592
Q3 2022 Added 0.23%
$1.09B
$33.6 Million 1.05% of portfolio
653,743
Q1 2025 New
$1.64B
$33.5 Million 1.04% of portfolio
999,000
Q4 2024 Reduced 4.86%
$1.99B
$31.8 Million 0.99% of portfolio
947,877
Q4 2024 Added 4.0%
$1.95B
$31.3 Million 0.98% of portfolio
1,432,300
Q1 2025 New
$9.26B
$29.4 Million 0.92% of portfolio
679,816
Q3 2024 Added 1.1%
$183M
$22.1 Million 0.69% of portfolio
6,943,654
Q3 2021 Reduced 13.78%
$135B
$22.1 Million 0.69% of portfolio
197,500
Q1 2025 Reduced 19.58%
$147M
$20.9 Million 0.65% of portfolio
7,562,971
Q3 2024 Reduced 0.74%
$978M
$20.5 Million 0.64% of portfolio
758,566
Q4 2024 Reduced 39.73%
$3.45B
$20.1 Million 0.63% of portfolio
380,000
Q1 2025 Reduced 5.0%
$210M
$20.1 Million 0.63% of portfolio
5,779,071
Q3 2022 New
$1.7B
$18.6 Million 0.58% of portfolio
2,285,400
Q4 2024 Added 300.74%
$425M
$16.3 Million 0.51% of portfolio
1,752,831
Q1 2025 Added 19.23%
$244M
$16 Million 0.5% of portfolio
13,135,260
Q4 2024 New
$111M
$15.9 Million 0.5% of portfolio
6,059,528
Q3 2024 Added 8.99%
$695M
$14.6 Million 0.45% of portfolio
2,248,249
Q1 2025 Reduced 30.15%
$399M
$14.6 Million 0.45% of portfolio
1,923,855
Q1 2025 Reduced 0.96%
$465M
$13.9 Million 0.43% of portfolio
3,087,462
Q4 2024 Added 53.88%
$155B
$13.8 Million 0.43% of portfolio
44,200
Q1 2025 New
$570M
$11.6 Million 0.36% of portfolio
481,065
Q1 2025 Reduced 35.22%
$75.8M
$10.9 Million 0.34% of portfolio
6,830,300
Q1 2025 Added 56.02%
$599M
$10.6 Million 0.33% of portfolio
1,014,611
Q1 2025 Reduced 17.32%
$352M
$10.4 Million 0.32% of portfolio
1,018,734
Q3 2024 Reduced 19.7%
$1.96B
$9.54 Million 0.3% of portfolio
325,500
Q1 2025 Added 1,119.1%
$901M
$9.32 Million 0.29% of portfolio
4,180,768
Q3 2021 Reduced 32.82%

Summary

  • Portfolio
  • No. of Stocks 111
  • Current Value $3.21 Billion
  • Prior Value $3.69 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 11 stocks
  • Additional Purchases 15 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 22 stocks
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email